@Breakingviews
ReutersBreakingviews
4 days ago
Vaccitech, which owns the technology behind AstraZeneca’s Covid-19 jab, has confidentially filed for an IPO in the U.S., the FT reports. It’s another snub for the UK’s drive to lure homegrown companies to the London Stock Exchange, writes @aimeedonnellan https://t.co/iEc6HJ330f https://t.co/fze6B0OMIC
Tweet media one
1
3
4

Replies

@DrD_McGregor
Duncan McGregor
4 days ago
@Breakingviews @aimeedonnellan No it’s not-hardly any UK biotechs float in the UK, or indeed in Europe. The biotech industry is based in the USA. Look at Immunocore-also floated on NASDAQ. It’s normal.
0
0
0